Skip to main content
OpenTrials

Clinical trial condition

Tuberculosis, Multidrug-Resistant

Explore clinical trials studying Tuberculosis, Multidrug-Resistant. Study availability and eligibility vary by location and protocol.

102 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Tuberculosis, Multidrug-Resistant trial results

Completed

Clinical Evaluation of tNGS for Diagnosis of DR-TB

NCT04239326

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +5 more
Locations
  • National Center for Tuberculosis and Lung Diseases Tbilisi, Georgia
  • Hinduja Hospital and Medical Research Centre Mumbai, Maharashtra, India
  • National Institute for Communicable Diseases & Wits Health Consortium Johannesburg, Sandringham, South Africa
View Trial Details
Completed

The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB

NCT02409290

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +6 more
Locations
  • Armauer Hanssen Research Institute Addis Ababa, Ethiopia
  • St. Peter's Tuberculosis Specializes Hospital Addis Ababa, Ethiopia
  • JSC National Center for Tuberculosis and Lung Diseases Tbilisi, Georgia
  • BJ Medical College Civil Hospital Ahmedabad, India
View all 13 locations
View Trial Details
Completed

Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis

NCT03086486

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +13 more
Locations
  • National Center for Tuberculosis and Lung Diseases Tbilisi, Georgia
  • Institute of Phthisiopneumology Chiril Draganiuc Chisinau, Moldova
  • Moscow City Research and Practice Tuberculosis Treatment Centre Moscow, Russia
  • Central TB Research Institute of the Federal Agency of Scientific Organizations Moscow Moscow, Russia
View Trial Details
Completed

DIAgnostics for Multidrug Resistant Tuberculosis in Africa

NCT03303963

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +8 more
Locations
  • Institute of Tropical Medecine Antwerp, Belgium
  • Centre National Hospitalier Universitaire de Pneumo-Phtisiologie de Cotonou Cotonou, Atlantique/Littoral, Benin
  • The Tuberculosis Reference Laboratory Bamenda Bamenda, Cameroon
  • Institut National de Recherche Biomédicale (INRB) Kinshasa, Democratic Republic of the Congo
View Trial Details
Completed

The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB

NCT03830671

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +6 more
Locations
  • Beijing Chest Hospital Beijing, China
  • The 8th Medical Center of Chinese Pla General Hospital Beijing, China
  • Changchun Infectious Disease Hospital Changchun, China
  • Hunan Institute For Tuberculosis Control Changsha, China
View all 20 locations
View Trial Details
Completed

Expand New Drugs for TB [endTB]

NCT03259269

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +5 more
Locations
  • National Treatment Centre for Tuberculosis, Abovian, Armenia Abovyan, Armenia
  • National Institute of Diseases of the Chest and Hospital (NIDCH), Dhaka Dhaka, Bangladesh
  • Republican Research and Practical Centre for Pulmonology and Tuberculosis Minsk, Belarus
  • Aung San Tuberculosis Hospital Yangon, Burma
View all 16 locations
View Trial Details
Completed

FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis

NCT02607449

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +6 more
Locations
  • Semey Medical University Semey, East Kazakhstan, Kazakhstan
  • West Kazakhstan Marat Ospanov Medical University Aktobe, West Kazakhstan, Kazakhstan
  • National scientific center of phthisiopulmonology Ministry of health of the Republic of Kazakhstan Almaty, Kazakhstan
  • Center of Phthisiopulmonology of the Public Health Administration of Almaty Almaty, Kazakhstan
View Trial Details
Completed

A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB)

NCT00685360

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +11 more
Locations
  • University of Texas Health Center at Tyler / Heartland National TB Center / Texas Center for Infectious Disease San Antonio, Texas, United States
  • Beijing Chest Hospital Beijing, China
  • Shanghai Pulmonary Hospital Shanghai, China
  • Abbassia Chest Hospital Cairo, Egypt
View all 17 locations
View Trial Details

Related conditions